|
Powered by Cell Signaling Technology |
Site Information |
---|
AFATQSGsQDLKALN SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 11423702 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Putative in vivo kinases: | |
Kinases, in vitro: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on EGR1: | |
Effects of modification on biological processes: | |
Inhibit interaction with: |
References | |
---|---|
Waldrip ZJ, et al. (2021) DNA-PKcs kinase activity stabilizes the transcription factor Egr1 in activated immune cells. J Biol Chem, 101209
34562454 Curated Info |
|
Jain N, et al. (1996) Casein kinase II associates with Egr-1 and acts as a negative modulator of its DNA binding and transcription activities in NIH 3T3 cells. J Biol Chem 271, 13530-6
8662759 Curated Info |